Search for a trial

A Phase 3, Randomized, Open-Label, Controlled, Multicenter Study of Zandelisib (ME-401) in Combination with Rituximab Versus Standard Immunochemotherapy in Patients with Relapsed Indolent Non-Hodgkin*s Lymphoma (iNHL) - The COASTAL Study

This study aims to test the hypothesis that zandelisib in combination with rituximab has better clinical activity and risk/benefit profile compared to standard 2nd line immunochemotherapy (R-CHOP/R-B) in subjects with relapsed FL or MZL. Primary…

*Follow that CAR!* - A prospective observational cohort study on CAR T-cell therapy for B-cell malignancies in the Netherlands

• To set up a national prospective observational cohort study of patients who have a hematological B-cell malignancy and are referred to the national CAR T-cell tumorboard for evaluation of eligibility for treatment with CAR T-cell therapy and to…

*Health-Related Quality of Life and disease-specific symptoms among Lymphoma and Multiple Myeloma survivors: A longitudinal PROFILES registry study. VITA-study*

The main objective is to assess HRQoL and (disease-specific) symptoms in patients with lymphoma or multiple myeloma. In addition, to identify demographic, clinical, biological, physiological and environmental characteristics of lymphoma and multiple…